AJMC August 16, 2021
Mary Caffrey

In recent years, genomic testing has changed the face of cancer care, as it helps ensure more informed decision-making between doctor and patient in cancer care. But precision medicine solutions cannot be delivered equitably if some patients lack access to testing, or if tests results are used incorrectly.

A June 2, 2021, webinar from Oncology Value Coalition, a series presented by The American Journal of Managed Care® (AJMC®), featured experts from City of Hope National Medical Center, of Duarte, California, and AccessHope LLC, which delivers cancer care to employers and their health care partners. The panel also featured a representative from Highmark Blue Cross Blue Shield, the integrated delivery network based in Pittsburgh, Pennsylvania. Serving as moderator was Joseph Alvarnas,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Health System / Hospital, Pharma / Biotech, Precision Medicine, Provider, Trends
Exploring the potential of personalized precision medicine for healthcare industry
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce

Share This Article